Prevalence of Psoriasis and Perceived Association with Hormone Therapy in Transgender Adults.

IF 2 4区医学 Q1 Social Sciences Transgender Health Pub Date : 2023-07-28 eCollection Date: 2023-08-01 DOI:10.1089/trgh.2021.0104

Hayley Braun, Elaine C Thompson, Qi Zhang, Vin Tangpricha, Michael Goodman, Howa Yeung

{"title":"Prevalence of Psoriasis and Perceived Association with Hormone Therapy in Transgender Adults.","authors":"Hayley Braun, Elaine C Thompson, Qi Zhang, Vin Tangpricha, Michael Goodman, Howa Yeung","doi":"10.1089/trgh.2021.0104","DOIUrl":null,"url":null,"abstract":"Purpose: The role of hormone therapy (HT) in the etiology and progression of psoriasis in the transgender population is unclear.Methods: The prevalence of psoriasis in transmasculine (TM) and transfeminine (TF) adults and perceived links between psoriasis and gender-affirming HT is examined using a cross-sectional survey of 696 transgender individuals.Results: Ever diagnosis of psoriasis was reported by 17 TM persons (4.9%; 95% confidence interval [CI]: 2.6-7.2) and 13 TF persons (3.7%; 95% CI: 1.7-5.7). Prevalence of current psoriasis in TM persons was 2.6% (95% CI: 0.9-4.3) and 1.1% (95% CI: 0.03-2.3) among TF persons. Notably, among participants who had ever had psoriasis, 17% perceived a link between their psoriasis and gender-affirming HT.Conclusions: Prevalence of psoriasis among transgender persons resembled estimates in the general population. Potential associations between psoriasis and its severity with gender-affirming HT warrant further longitudinal research.","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387154/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transgender Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/trgh.2021.0104","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Social Sciences","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: The role of hormone therapy (HT) in the etiology and progression of psoriasis in the transgender population is unclear.

Methods: The prevalence of psoriasis in transmasculine (TM) and transfeminine (TF) adults and perceived links between psoriasis and gender-affirming HT is examined using a cross-sectional survey of 696 transgender individuals.

Results: Ever diagnosis of psoriasis was reported by 17 TM persons (4.9%; 95% confidence interval [CI]: 2.6-7.2) and 13 TF persons (3.7%; 95% CI: 1.7-5.7). Prevalence of current psoriasis in TM persons was 2.6% (95% CI: 0.9-4.3) and 1.1% (95% CI: 0.03-2.3) among TF persons. Notably, among participants who had ever had psoriasis, 17% perceived a link between their psoriasis and gender-affirming HT.

Conclusions: Prevalence of psoriasis among transgender persons resembled estimates in the general population. Potential associations between psoriasis and its severity with gender-affirming HT warrant further longitudinal research.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

变性成人的银屑病患病率及与激素治疗的关系。

目的：激素疗法（HT）在跨性别人群银屑病的病因和发展中的作用尚不清楚：方法：通过对 696 名跨性别者进行横断面调查，研究跨男性化（TM）和跨女性化（TF）成年人的银屑病患病率，以及银屑病与性别确认 HT 之间的关系：有 17 名变性人（4.9%；95% 置信区间 [CI]：2.6-7.2）和 13 名变性人（3.7%；95% 置信区间：1.7-5.7）曾被诊断出患有银屑病。目前患有银屑病的 TM 患者为 2.6%（95% 置信区间：0.9-4.3），TF 患者为 1.1%（95% 置信区间：0.03-2.3）。值得注意的是，在曾经患有银屑病的参与者中，17%的人认为其银屑病与性别认同 HT 之间存在联系：结论：变性人的银屑病发病率与普通人群的估计值相似。银屑病及其严重程度与性别认同 HT 之间的潜在关联值得进一步开展纵向研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊